Limited Coverage Drugs - duloxetine

Generic Name

duloxetine

Strength

30 mg, 60 mg

Form

delayed-release capsules

Special Authority Criteria

Approval Period

For the treatment of neuropathic pain in adult patients, when the patient has had an inadequate response to trials of gabapentin and at least 1 tricyclic antidepressant agent.

Indefinite

Practitioner Exemptions

  • None

Special Notes

  • Special Authority coverage of duloxetine for the treatment of neuropathic pain is available for up to a maximum dose of 60 mg/day.
  • PharmaCare also covers duloxetine for patients enrolled in Plan P, BC Palliative Care Benefits Program, as a regular benefit at a maximum dose of 60 mg/day.

Special Authority Request Form